Maus anti-Human IgM Antikörper
(1 reference)Kurzübersicht für Maus anti-Human IgM Antikörper (ABIN2474845)
Target
Klonalität
Applikation
Klon
Isotyp
-
-
Reaktivität
- Human
-
Wirt
- Maus
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
-
Mouse anti-Human IgM antibody (FITC)
FACS Monoclonal CH2 IgG1 kappa FITC
Mouse anti-Human IgM antibody (APC)FACS Monoclonal CH2 IgG1 kappa APC
Mouse anti-Human IgM antibody (HRP)ELISA, WB Monoclonal CH2 IgG1 kappa HRP
Mouse anti-Human IgM antibody (PE)FACS Monoclonal CH2 IgG1 kappa PE
Rabbit anti-Human IgM antibodyELISA, IHC, WB Polyclonal unconjugated
Goat anti-Human IgM (Heavy Chain) antibody (TRITC)ELISA, FACS, IHC Polyclonal IgG TRITC
Goat anti-Human IgM (Heavy Chain) antibody (FITC)ELISA, FACS, IHC Polyclonal IgG FITC
Goat anti-Human IgM (Heavy Chain) antibody (Texas Red (TR))ELISA, FACS, IHC Polyclonal IgG Texas Red (TR)
Goat anti-Human IgM antibody - PreadsorbedELISA, FLISA Polyclonal IgG unconjugated
Goat anti-Human IgM antibody (HRP) - PreadsorbedELISA, FLISA Polyclonal IgG HRP
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte ..." in: International journal of hematology, Vol. 91, Issue 3, pp. 501-8, (2010) (PubMed).
-
: "Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte ..." in: International journal of hematology, Vol. 91, Issue 3, pp. 501-8, (2010) (PubMed).
-
- IgM
-
Substanzklasse
- Antibody
-
Gen-ID
- 3507
-
UniProt
- P01871
Target
-
